drugset / Trial / NCT01923480

Dosing Study of Amino Acids in Seriously Ill Patients

NCT01923480 ↗

Phase 4 Terminated 16 enrolled Baxter Healthcare Corporation
RandomizedCrossoverOpen-labelSupportive care

Summary

The purpose of this study is to determine the best rate of infusion of amino acids (15% CLINISOL - sulfite-free (Amino Acid) Injection) for nutrition in subjects with with stages II to IVB head and neck cancer.

Timeline

Start
2013-07
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject CLINISOL Unknown 0.04 g/kg —
Subject CLINISOL Unknown 0.08 g/kg —
Subject CLINISOL Unknown 0.13 g/kg —

Indications

No indication recorded.